Bio
Joshua Rich, a partner in Lippes Mathias' Intellectual Property Practice Team, brings over 30 years of experience as an intellectual property trial attorney and client counselor across a broad range of matters. He has achieved success for clients in federal and state trial and appellate courts throughout the United States in patent, trade secret, trademark, copyright, and other commercial disputes. He has also reached positive outcomes for clients before the United States Patent and Trademark Office in inter partes review, reexamination, and interference proceedings, as well as in international arbitrations.
While Joshua has primarily represented clients in the pharmaceutical, biotechnology, and medical device sectors, his expertise extends to diverse technologies including telecommunications, computer code, and graphical user interfaces. He demonstrates proficiency across all aspects of trial and appellate litigation, from pretrial seizures and preliminary injunction proceedings through bench and jury trials, appeals, and certiorari petitions.
Joshua is also a sought-after voice of expertise on artificial intelligence (AI) issues. He provides counseling on AI use policies, as well as privacy and intellectual property concerns. He works closely with clients to help them adopt AI use policies that will not only protect the clients’ assets, but also will be implementable to help the clients’ businesses leverage the gains of AI. He has also spoken and published often on how AI effects businesses’ and clients’ data and policies.
Prior to joining Lippes, Joshua served as his firm’s general counsel. That experience has helped him view representation from the client’s point of view. He seeks the best outcome for clients’ business, whether that means a trial, a negotiated settlement, or even avoiding problems in the first place.
Representative Matters
- Obtained summary judgment of patent noninfringement and invalidity for a major medical device manufacturer.
- Coordinated an international arbitration for a major pharmaceutical company in a patent license dispute, leading to a multimillion-dollar award for the client.
- Obtained summary judgment of patent infringement for a major pharmaceutical company, leading to a favorable settlement.
- Obtained a preliminary injunction in a patent infringement case for a major animal diagnostic device manufacturer, leading to withdrawal of a competing product from the market.
- Secured denial of a motion for preliminary injunction for a major pharmaceutical company in a drug patent infringement case based on a finding of “little or no likelihood of success on the merits” due to invalidity, leading to a settlement in which the plaintiff paid Mr. Rich’s client.
- Represented several major pharmaceutical companies in ANDA litigation through trial, leading to favorable settlements.
- Defended several major diagnostics companies in patent infringement litigation, leading to favorable settlements with immediate access to the market.
- Obtained institution of inter partes review petitions, leading to favorable settlements.
- Prevailed in interference proceedings for a plastics company, securing critical patent rights for its products.
- Prevailed in motions relating to attorney-client privilege for a plastics company, which established important legal principles and led to favorable settlements in patent infringement litigation.
- Negotiated license and research and development agreements that allowed a food ingredients company to build a new portfolio of products.
- Authored amicus curiae briefs in landmark patent, trademark, copyright, and other cases in U.S. Courts of Appeals and the U.S. Supreme Court.
Articles & Publications
- Author, "USPTO Proposed New Rules Limiting the Availability of Inter Partes Review, But Are They Legal?" JD Supra, October 20, 2025
- Co-author, "Death and Taxes Should not be Certainties for the Patent System," JD Supra, July 30, 2025
- Co-author, "AI Hallucination in Legal Cases Remain a Problem," JD Supra, June 5, 2025
- Author, "ABA Issues Formal Ethics Opinion on Use of Generative AI Tools," JD Supra, August 20, 2024
- Co-author, "The No Fakes Act: Bipartisan Group of Senators Introduce Bill to Protect Against Unauthorized Uses of Digital Replicas," JD Supra, August 6, 2024
- Author, "The USPTO's Guidance on Use of AI-Based Tools in Practice," JD Supra, April 16, 2024
- Author, "College Football's Latest Controversy: NCAA IP-Like 'Sign Stealing' Rules Not Ready for Big Data or AI," JD Supra, November 27, 2023
- Co-author, "Supreme Court Retains Doctrine of Assignor Estoppel, But with Limits," JD Supra, July 6, 2021
- Author, "Supreme Court Prohibits Use of Federal 'Anti-Hacking' Law Against Those Who Use Otherwise Authorized Access for Improper Purpose," JD Supra, June 4, 2021
- Author, "Supreme Court Expands Trade Secrets Exemption from FOIA," JD Supra, December 20, 2019
- Author, "U.S. Supreme Court Refuses to Require Applicants to Pay USPTO's Attorney Fees in District Court 'Appeals' of Prosecution Decisions," JD Supra, December 11, 2019
- Author, "U.S. Supreme Court Ruling in Return Mail v. U.S. Postal Service Prohibiting Federal Agencies from Seeking AIA Review," JD Supra June 19, 2019
- Author, "Protecting Trade Secrets with Restrictive Covenants: The Question of Consideration in Illinois," JD Supra March 18, 2019
- Author, "PTAB Adopts Litigation Standards for Claim Construction in AIA Proceedings," JD Supra, October 12, 2018
- Author, "New York v. Aleynikov -- On Second Thought, New York State's Penal Code (Unlike Federal Criminal Law) Covers Electronic Reproduction of Source Code," JD Supra, May 14, 2018
- Author, "ABA Provides Guidance on Required Disclosure of Attorney Errors," JD Supra, April 20, 2018
- Author, "In re Silver -- Texas Supreme Court Recognizes Patent Agent Privilege," JD Supra, February 27, 2018
- Author, "USPTO Issues Final Rule Establishing Patent Agent Privilege," JD Supra, November 8, 2017
- Author, "The DTSA After One Year: Has the Federal Trade Secrets Law Met Expectations," JD Supra, September 11, 2017
- Author, "Patent Office Ethics Developments: Patent Agent Privilege and Duty of Disclosure," JD Supra, March 17, 2017
Related Content
View All
Press Releases
Lippes Mathias Partner Joshua R. Rich Speaks on AI and Patent Practice at 2025 BIO IP Conference
November 17, 2025
Articles
USPTO Director Squires Will Personally Make All IPR and PGR Institution Decisions
October 30, 2025
In The news
Intellectual Property Attorney Joshua R. Rich Authors Analysis of Inland Diamond Products v. Cherry Optical and the Gap Between IPRs and District Courts
October 27, 2025
In The news
Patent Attorney Joshua R. Rich Explores Legality of USPTO’s Proposed IPR Restrictions in Recent Blog
October 19, 2025
Press Releases
Intellectual Property Attorney Joshua R. Rich Joins Lippes Mathias LLP as Partner in Chicago Office
September 8, 2025